Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Albert

Showing results (231-240 of 437) with videos related to

Pageof 44
Sort By:
Frontiers in Microbiology|April 2, 2013
Microbes on the cliff: alpine cushion plants structure bacterial and fungal communitiesJ Roy, C H Albert, S Ibanez, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 30, 2017
Allogeneic stem cell transplantation in adolescents and young adults with primary immunodeficienciesMichael H Albert, Fabian Hauck, Volker Wiebking, et al.
Blood|February 1, 2007
Intravenous immunoglobulins contain naturally occurring antibodies that mimic antineutrophil cytoplasmic antibodies and activate neutrophils in a TNFalpha-dependent and Fc-receptor-independent waySven Jarius, Peter Eichhorn, Michael H Albert, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 21, 2011
ABT-869, a multitargeted receptor tyrosine kinase inhibitor, reduces tumor microvascularity and improves vascular wall integrity in preclinical tumor modelsFang Jiang, Daniel H Albert, Yanping Luo, et al.
Journal of Inherited Metabolic Disease|March 1, 2019
Allogeneic hematopoietic cell transplantation in Farber diseaseKaroline Ehlert, Thierry Levade, Maja Di Rocco, et al.
Shock (Augusta, Ga.)|August 1, 1996
ABT-299, a novel PAF antagonist, attenuates multiple effects of endotoxemia in conscious ratsD H Albert, G Luo, T J Magoc, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
5-lipoxygenase inhibitory activity of zileutonG W Carter, P R Young, D H Albert, et al.
Journal of Medicinal Chemistry|May 29, 1992
Synthesis and structure-activity relationships of a series of novel benzopyran-containing platelet activating factor antagonistsD E Guinn, J B Summers, H R Heyman, et al.
Molecular Cancer Therapeutics|December 2, 2016
HEXIM1 as a Robust Pharmacodynamic Marker for Monitoring Target Engagement of BET Family Bromodomain Inhibitors in Tumors and Surrogate TissuesXiaoyu Lin, Xiaoli Huang, Tamar Uziel, et al.
Transplantation and Cellular Therapy|September 14, 2023
Predicting Patient Death after Allogeneic Stem Cell Transplantation for Inborn Errors Using Machine Learning (PREPAD): A European Society for Blood and Marrow Transplantation Inborn Errors Working Party StudyErik G J von Asmuth, Bénédicte Neven, Michael H Albert, et al.
Pageof 44

Showing results (231-240 of 437) with videos related to

Sort By:
Pageof 44
Frontiers in Microbiology|April 2, 2013
Microbes on the cliff: alpine cushion plants structure bacterial and fungal communitiesJ Roy, C H Albert, S Ibanez, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 30, 2017
Allogeneic stem cell transplantation in adolescents and young adults with primary immunodeficienciesMichael H Albert, Fabian Hauck, Volker Wiebking, et al.
Blood|February 1, 2007
Intravenous immunoglobulins contain naturally occurring antibodies that mimic antineutrophil cytoplasmic antibodies and activate neutrophils in a TNFalpha-dependent and Fc-receptor-independent waySven Jarius, Peter Eichhorn, Michael H Albert, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 21, 2011
ABT-869, a multitargeted receptor tyrosine kinase inhibitor, reduces tumor microvascularity and improves vascular wall integrity in preclinical tumor modelsFang Jiang, Daniel H Albert, Yanping Luo, et al.
Journal of Inherited Metabolic Disease|March 1, 2019
Allogeneic hematopoietic cell transplantation in Farber diseaseKaroline Ehlert, Thierry Levade, Maja Di Rocco, et al.
Shock (Augusta, Ga.)|August 1, 1996
ABT-299, a novel PAF antagonist, attenuates multiple effects of endotoxemia in conscious ratsD H Albert, G Luo, T J Magoc, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
5-lipoxygenase inhibitory activity of zileutonG W Carter, P R Young, D H Albert, et al.
Journal of Medicinal Chemistry|May 29, 1992
Synthesis and structure-activity relationships of a series of novel benzopyran-containing platelet activating factor antagonistsD E Guinn, J B Summers, H R Heyman, et al.
Molecular Cancer Therapeutics|December 2, 2016
HEXIM1 as a Robust Pharmacodynamic Marker for Monitoring Target Engagement of BET Family Bromodomain Inhibitors in Tumors and Surrogate TissuesXiaoyu Lin, Xiaoli Huang, Tamar Uziel, et al.
Transplantation and Cellular Therapy|September 14, 2023
Predicting Patient Death after Allogeneic Stem Cell Transplantation for Inborn Errors Using Machine Learning (PREPAD): A European Society for Blood and Marrow Transplantation Inborn Errors Working Party StudyErik G J von Asmuth, Bénédicte Neven, Michael H Albert, et al.
Pageof 44